control reaction. No oxidation was observed for (¡)-5 with any of
the conditions tested.
reduce the enzyme bound FAD. Unfortunately, the enantioselec-
tivity displayed by the enzymes in these conditions was
disappointingly low. The presence of NADP+ in the reaction
medium restored selectivity. This suggests that the role of NADPH
in the catalytic process is not only that of a mere reducing agent: it
enhances the enantioselectivity by properly shaping the active site
of these enzymes.
On the whole, the results indicate that the enantioselectivity
displayed by the four studied BVMOs in the oxidation of sulfides
is very low, when using only 1 as a coenzyme substitute. Similar
results (ee 26%) were previously obtained with another mono-
oxygenase, styrene monooxygenase (StyA),13 in the oxidation of 4
to 5.4 The lack of enantioselectivity might be ascribed to i)
formation of hydrogen peroxide obtained through oxygen
reduction2 by 1 and consequent abiotic oxidation of the sulfide
to the racemic sulfoxide or ii) spontaneous sulfide oxidation by air.
However, these hypotheses were ruled out by the fact that in
control experiments, conducted in the presence of the various
reagents but without the monooxygenases, the formation of
sulfoxides did not occur. Thus, sulfoxides are produced by genuine
enzyme catalysis and, more importantly, 1 is able to reduce the
FAD associated with the enzymes.
We thank CERC3 for funding and G. d. G. thanks FICYT
(Principado de Asturias, Spain) for a postdoctoral fellowship.
COST D25/0005/03 is gratefully acknowledged.
Notes and references
{ General method for enzymatic oxidations using the rhodium complex as
coenzyme: the organic sulfide or sulfoxide (1.9–2.7 mg; 16 mmol L21) was
added to potassium phosphate buffer (50 mM, pH 9.0, 0.9 mL) containing
sodium formate (6.8 mg; 0.1 M), an aqueous solution of 1 (100 mM,
0.1 mL), 1.0 U of the flavin containing monooxygenase and acetanilide
(0.02 mg) as an internal standard. When necessary, different amounts of
NADP+ were added. The system was shaken at 250 rpm and 25 uC. The
reaction was then stopped, worked up and analyzed by chiral HPLC
Although styrene monooxygenase and BVMOs are closely
related enzymes, there are differences in the role of FAD. In
styrene monooxygenase the cofactor is loosely bound to the
enzyme and can diffuse in the medium,13 whereas in the studied
BVMOs the flavin cofactor is tightly bound to the enzyme, which
implies that 1a has to enter the enzyme active site in order to
reduce the cofactor. This latter hypothesis is also supported by the
finding that it is possible to accommodate 1a, by manual docking,
in the active site of PAMO (data not shown). Because of the
bulkiness of 1a compared to that of NADPH, we must also
assume a certain degree of enzyme flexibility to make it possible to
accommodate 1a in enzyme active site.
When NADP+ is present in the medium, it is likely that the
reaction mechanism is not as simple as illustrated in Scheme 2,
part b. A more reliable representation might be that both 1a and
NADPH compete for the same active site. This view is also
supported by literature kinetic data demonstrating that 1a is more
efficient in reducing NADP+ to NADPH than FAD to FADH2.2
Therefore a decrease in concentration of 1 (e.g. from 10 to 1 mM)
and an increase in that of NADP+ (e.g. from 0 to 1.3 mM) will
decrease the fraction of FAD directly reduced by 1a (Scheme 2,
part a) and increase that reduced through NADPH (Scheme 2,
part b). This partial switch of mechanism was also reflected in the
general increase of both conversion and enantiomeric excess. For
example, with PAMO the recovery of the enantioselectivity was
full when supplementing the system with NADP+ (Table 1, entries
4 and 5). The different influence of 1a and NADPH on enzyme
enantioselectivity is quite intriguing. It has been shown previously
that, in the catalytic cycle of BVMOs, NADPH is bound to the
enzyme during the substrate oxidation step.14 We hypothesize that,
as NADP+ is bound during the oxidation reaction, it is also part of
the active site cavity, thereby tuning the (enantio)selectivity of the
enzyme. Instead 1a, even if able to reduce FAD, will not show any
real affinity for the enzyme and will diffuse from the active site
before oxidation takes place. Therefore, in this case, the enzyme
active site will be less defined, resulting in lowered selectivity.
In conclusion, we have demonstrated that 1/formate can be used
as a coenzyme substitute in BVMO oxidations as 1a is able to
(Chiracel OD, Daicel, chiral column; l254 nm; flow rate 1 mL min21
;
eluent: light petroleum ether, i-PrOH).12
1 J. H. van Esch, M. A. M. Hoffmann and R. J. M. Nolte, J. Org. Chem.,
1995, 60, 1599.
2 H. Christine Lo, O. Buriez, J. B. Kerr and R. H. Fish, Angew. Chem.
Int. Ed., 1999, 38, 1429; F. Hollmann, A. Schmid and E. Steckhan,
Angew. Chem. Int. Ed., 2001, 40, 169; F. Hollmann, B. Witholt and
A. Schmid, J. Mol. Catal. B: Enzym., 2003, 19–20, 167; J. Lutz,
F. Hollmann, T. V. Ho, A. Schnyder, R. H. Fish and A. Schmid,
J. Organomet. Chem., 2004, 689, 4783.
3 U. Ko¨lle and M. Gra¨tzel, Angew. Chem., 1987, 99, 572.
4 F. Hollmann, P.-C. Lin, B. Witholt and A. Schmid, J. Am. Chem. Soc.,
2003, 125, 8209.
5 E. Malito, A. Alfieri, M. W. Fraaije and A. Mattevi, Proc. Natl. Acad.
Sci. U. S. A., 2004, 101, 13157; M. W. Fraaije, J. Wu, D. P. H.
M. Heuts, E. W. van Hellemond, J. H. Lutje Spelberg and D. B. Janssen,
Appl. Microbiol. Biotechnol., 2005, 66, 393.
6 N. M. Kamerbeek, M. J. H. Moonen, J. G. M. van der Ven, W. J.
H. van Berkel, M. W. Fraaije and D. B. Janssen, Eur. J. Biochem., 2001,
268, 2547; N. M. Kamerbeek, A. J. J. Olsthoorn, M. W. Fraaije and
D. B. Janssen, Appl. Environ. Microbiol., 2003, 419.
7 N. A. Donoghue, D. B. Norris and P. W. Trudgill, Eur. J. Biochem.,
1976, 63, 175; S. D. Doig, L. M. O’Sullivan, S. Patel, J. M. Ward and
J. M. Woodley, Enzyme Microb. Technol., 2001, 28, 265.
8 M. W. Fraaije, N. M. Kamerbeek, A. J. Heidekamp, R. Fortin and
D. B. Janssen, J. Biol. Chem., 2004, 5, 279.
9 M. W. Fraaije, N. M. Kamerbeek, W. J. H. van Berkel and
D. B. Janssen, FEBS Lett., 2002, 518, 43.
10 S. M. Roberts and P. W. H. Wan, J. Mol. Catal. B: Enzym., 1998, 4,
111; V. Alphand, G. Carrea, R. Wohlgemuth, R. Furstoss and
J. M. Woodley, Trends Biotechnol., 2003, 21, 318; N. M. Kamerbeek,
D. B. Janssen, W. J. H. Berkel and M. W. Fraaije, Adv. Synth. Catal.,
2003, 345, 667; M. D. Mihovilovic, F. Rudroff and B. Gro¨tzl, Curr. Org.
Chem., 2004, 8, 1057.
11 I. Ferna´ndez and N. Khiar, Chem. Rev., 2003, 103, 3651; J. Legros,
J. R. Dehli and C. Bolm, Adv. Synth. Catal., 2005, 347, 19.
12 S. Colonna, N. Gaggero, P. Pasta and G. Ottolina, Chem. Commun.,
1996, 2303; S. Colonna, S. Del Sordo, N. Gaggero, G. Carrea and
P. Pasta, Heteroat. Chem., 2002, 13, 467; F. Zambianchi, S. Raimondi,
P. Pasta, G. Carrea, N. Gaggero and J. A. Woodley, J. Mol. Catal. B:
Enzym., 2004, 31, 165.
13 K. Otto, K. Hofstetter, M. Ro¨thlisberger, B. Witholt and A. Schmid,
J. Bacteriol., 2004, 186, 5292.
14 D. Sheng, D. P. Ballou and V. Massey, Biochemistry, 2001, 40, 11156.
3726 | Chem. Commun., 2005, 3724–3726
This journal is ß The Royal Society of Chemistry 2005